Predictive Value of Retroperitoneal Fat Area Measurement for Detecting Metabolic Syndrome in Patients Undergoing Adrenalectomy

Abstract

Visceral obesity is one of the main components of the metabolic syndrome (MetS). The retroperitoneal fat area (RFA) is part of the intraabdominal adipose mass. The aim of this clinical trial was to determine whether there is an association between the RFA measurement and MetS components in patients undergoing laparoscopic lateral transabdominal adrenalectomy.